VKT Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: VKT Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $8.9M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

VKT Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $8.9M Trade | TransData Nexus

VKT Pharma Private Limited

Indian Pharmaceutical Exporter · Gastrointestinal Specialist · $8.9M Total Trade · DGFT Verified

VKT Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $8.9M across 2 products in 1 therapeutic categories. Based on 179 verified export shipments from Indian Customs (DGFT) records, VKT Pharma Private Limited is the #1 Indian exporter in 1 product including Famotidine. Top exports include Famotidine ($8.7M), Ranitidine ($216.8K), .

VKT Pharma Private Limited — Export Portfolio & Destination Treemap

VKT Pharma Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is VKT Pharma Private Limited? — Company Overview & Market Position

VKT Pharma Private Limited, established on May 31, 2006, is a privately held pharmaceutical company headquartered in Hyderabad, Telangana, India. The company is registered under the Corporate Identification Number (CIN) U24100TG2006PTC050221. As of March 31, 2025, VKT Pharma reported an authorized capital of ₹12.00 crore and a paid-up capital of ₹11.06 crore. The company employs approximately 238 professionals, reflecting its commitment to quality and innovation in the pharmaceutical sector.

VKT Pharma specializes in the development, manufacturing, and marketing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio is primarily focused on the gastrointestinal therapeutic category, with Famotidine and Ranitidine being the top exported products. In 2022, VKT Pharma's total export value was $8.9 million USD, encompassing 179 shipments across two products. Famotidine led the market with a 15.5% share, while Ranitidine held a 1.7% share.

What Does VKT Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Famotidine$8.7M

Product Portfolio — Top 2 by Export Value

VKT Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Famotidine	Gastrointestinal	$8.7M	173	15.5%	1
2	Ranitidine	Gastrointestinal	$216.8K	6	1.7%	11

VKT Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $8.9M. The company is the #1 Indian exporter in 1 product: Famotidine. The top category is Gastrointestinal (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

VKT Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

VKT Pharma operates a state-of-the-art manufacturing facility located in Derasam Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh. This plant is equipped to produce high volumes of solid dosage forms, including tablets, capsules, and ready-to-fill immediate or modified release pellets. The facility adheres to stringent quality standards, ensuring compliance with current Good Manufacturing Practices (cGMP) and other regulatory requirements.

3Key Leadership

The leadership team at VKT Pharma is headed by Managing Director Vamsi Krishna Potluri, who has been instrumental in steering the company's strategic direction and growth. Other key executives include Ramesh Babu Potluri and Hima Bindu Potluri, both serving as Directors. Their combined expertise and vision have been pivotal in establishing VKT Pharma as a significant player in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does VKT Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

VKT Pharma has made significant strides in expanding its presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has successfully undergone audits by the US FDA and EU GMP, achieving compliance with their stringent standards. In 2018, VKT Pharma received WHO GMP accreditation, further solidifying its commitment to quality. These regulatory approvals have facilitated the company's entry into these markets, enabling it to offer a range of pharmaceutical products that meet international quality standards.

2Emerging Markets

VKT Pharma has also focused on penetrating emerging markets in Africa, Latin America, and Southeast Asia. The company's WHO prequalification status has been instrumental in gaining access to these regions, allowing it to supply essential medicines that meet global quality standards. This strategic approach has enabled VKT Pharma to address the growing demand for affordable and high-quality pharmaceuticals in these markets.

3Geographic Strategy

VKT Pharma's geographic strategy demonstrates a balanced approach, with a strong focus on both regulated and emerging markets. The company's significant export value of $8.9 million USD in 2022, primarily from Famotidine and Ranitidine, indicates a concentrated product portfolio. While this concentration offers specialization, it also presents risks associated with dependency on a limited number of products. VKT Pharma's expansion into diverse geographic regions aims to mitigate these risks and leverage growth opportunities across different markets.

VKT Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

VKT Pharma has achieved FDA facility registrations, demonstrating its compliance with US regulatory standards. The company has also filed Abbreviated New Drug Applications (ANDAs) for its products, facilitating market access in the United States. Additionally, VKT Pharma has submitted Drug Master Files (DMFs), providing detailed information about its manufacturing processes and quality controls. The company's facilities have undergone FDA inspections, reflecting its commitment to maintaining high-quality manufacturing practices.

2WHO & EU GMP

VKT Pharma holds WHO GMP accreditation, affirming its adherence to international manufacturing standards. The company has also successfully passed EU GMP audits, ensuring its products meet the quality requirements of the European market. These certifications underscore VKT Pharma's dedication to producing pharmaceuticals that comply with global quality benchmarks.

3CDSCO & Indian Regulatory

In India, VKT Pharma operates under the guidelines set by the Central Drugs Standard Control Organisation (CDSCO). The company holds manufacturing licenses and approvals from state drug controllers, ensuring compliance with national regulatory standards. VKT Pharma also possesses export No Objection Certificates (NOCs), facilitating the export of its products to various international markets.

VKT Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

VKT Pharma operates in a competitive landscape with several key players in the gastrointestinal therapeutic category. While specific market share data is not publicly disclosed, VKT Pharma's focus on high-quality formulations and adherence to international standards positions it favorably against competitors. The company's strategic expansion into both regulated and emerging markets further enhances its competitive edge.

2Key Differentiators

VKT Pharma's key differentiators include its vertically integrated business model, encompassing research and development, manufacturing, and marketing of pharmaceutical products. The company's commitment to quality is evident through its compliance with cGMP and international certifications such as WHO GMP and EU GMP. Additionally, VKT Pharma's focus on novel drug delivery systems and contract research and manufacturing services (CRAMS) allows it to offer innovative solutions to its clients.

3Strategic Position

VKT Pharma's current strategic direction emphasizes the development of generic formulations, with a particular focus on complex molecules and novel drug delivery systems. The company's expansion into both regulated and emerging markets reflects its commitment to global growth and accessibility. Looking ahead, VKT Pharma aims to strengthen its position in the global pharmaceutical industry by leveraging its integrated capabilities and dedication to quality.

Buyer Due Diligence Brief — Evaluating VKT Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

VKT Pharma has demonstrated a consistent track record in manufacturing and exporting pharmaceutical products. The company's export volume of $8.9 million USD in 2022, with 179 shipments, indicates reliability and capacity. VKT Pharma's adherence to international quality standards and regulatory approvals further underscores its dependability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and compliance:

FDA Facility Registration: Confirm VKT Pharma's registration status with the US FDA to ensure compliance with US regulations.

WHO GMP Accreditation: Verify the company's WHO GMP certification to ensure adherence to international manufacturing standards.

EU GMP Certification: Check for EU GMP certification to confirm compliance with European Union quality standards.

Frequently Asked Questions — VKT Pharma Private Limited

How many pharmaceutical products does VKT Pharma Private Limited export from India?

VKT Pharma Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Famotidine ($8.7M), Ranitidine ($216.8K). Total export value is $8.9M.

What is VKT Pharma Private Limited's total pharmaceutical export value?

VKT Pharma Private Limited's total pharmaceutical export value is $8.9M, based on 179 verified shipments recorded in Indian Customs (DGFT) data.

In which products is VKT Pharma Private Limited the #1 Indian exporter?

VKT Pharma Private Limited is the #1 Indian exporter in 1 products: Famotidine (15.5% market share).

What therapeutic categories does VKT Pharma Private Limited cover?

VKT Pharma Private Limited exports across 1 therapeutic categories. The largest are Gastrointestinal (100.0%, 2 products).

Get Full VKT Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.